ALIGOS THERAPEUTICS INC

CUSIP: 01626L105 Class: Stock

Versant Venture Management, LLC's Holding History (CIK: 0001560009)

Note: Option positions (PUT/CALL) are excluded.

Q2 2024
Shares 1,457,937 Value ($000) $510 Avg Close — Range —
Q1 2024
Shares 2,320,381 Value ($000) $2,274 Avg Close — Range —
Q4 2023
Shares 2,320,381 Value ($000) $1,541 Avg Close — Range —
Q3 2023
Shares 2,320,381 Value ($000) $1,733 Avg Close — Range —
Q2 2023
Shares 2,320,381 Value ($000) $2,253 Avg Close — Range —
Q1 2023
Shares 2,320,381 Value ($000) $2,028 Avg Close — Range —
Q4 2022
Shares 2,320,381 Value ($000) $2,211 Avg Close — Range —
Q3 2022
Shares 2,320,381 Value ($000) $2,552 Avg Close — Range —
Q2 2022
Shares 2,320,381 Value ($000) $2,808 Avg Close — Range —
Q1 2022
Shares 2,320,381 Value ($000) $4,989 Avg Close — Range —
Q4 2021
Shares 2,320,381 Value ($000) $27,543 Avg Close — Range —
Q3 2021
Shares 2,320,381 Value ($000) $35,989 Avg Close — Range —
Q2 2021
Shares 2,320,381 Value ($000) $47,301 Avg Close — Range —
Q1 2021
Shares 3,292,339 Value ($000) $74,868 Avg Close — Range —
Q4 2020
Shares 3,292,339 Value ($000) $91,033 Avg Close — Range —